Skip to main content

Development of a Child Psychopharmacology Trial Scale

Buy Article:

$63.00 plus tax (Refund Policy)


Psychotropic prescriptions for children and adolescents are on the rise. Until recently, pediatric psychopharmacology practice was extrapolated from adult data. While over 70% of pediatric psychopharmacology prescriptions were “off label”, evidence grew of differences between pediatric and adult biological properties and psychosocial factors. Spurred by recent U.S. Congressional legislation, there have been many newly published studies on safety, tolerability, and efficacy for medications in children and adolescents. Traditional methods for clinicians to evaluate these trials are qualitative, confusing to many, difficult to use as a comparison between studies, and do not account for important issues specific to the pediatric population. This paper describes the initial development of the Child Psychopharmacology Trial Scale (CPTS). A Medline review of the past 20 years on scale development along with interviews with expert psychopharmacologists and scale developers were conducted. A thorough yet concise scale was developed and tested in a pilot study to assess for feasibility. This one-page scale is presented. The CPTS provides 1) a standard evaluation of appropriate study design, 2) a confidence index for the clinician who wants to base his/her drug selection from available pediatric studies, 3) a standard to compare among studies, and 4) an effort to promote better science in pediatric trials. The CPTS has good face validity. Results will aid further development. It is to our knowledge the first attempt to quantify the quality of studies in the field of pediatric psychopharmacology.

Keywords: Anxiety; Child Psychopharmacology; Evaluation; Extensions; Hyperactivity; Mental Health; filtration; medication; pediatrics; psychopharmacology; randomization; scale; suicidal; tolerability; trial

Document Type: Research Article

Publication date: 2012-02-01

More about this publication?
  • Current Psychopharmacology publishes peer-reviewed expert review articles and single topic guest edited issues on all aspects of pre-clinical and clinical research in psychopharmacology. The journal aims to be the leading forum for expert review articles in the field. The journal also accepts high-level original research articles on outstanding topics of preclinical and clinical psychopharmacology. Data must be published for the first time in Current Psychopharmacology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more